Molecule Details
InChIKeyUQRCJCNVNUFYDX-UHFFFAOYSA-N
Compound NameGolvatinib
Canonical SMILESCN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)27
Pfam Stratification Cross-Family
Avg pChEMBL6.85
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11977
Drug NameGolvatinib
CAS Number928037-13-2
Groups investigational
ATC Codes nan
DescriptionGolvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.

Categories: Amines Pyridines Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
Cross-references: BindingDB: 50100615 CHEMBL3039525 ChemSpider: 17275597 PDB: GV0 PubChem:16118392 PubChem:347828299 ZINC: ZINC000043195317
Target Activities (27)
Target Gene Organism Category Pfam pChEMBL Type Source
P36888 FLT3 Homo sapiens Human PF00047 PF07714 8.4 Kd ChEMBL
Q08345 DDR1 Homo sapiens Human PF21114 PF00754 PF07714 8.3 Kd ChEMBL
P08581 MET Homo sapiens Human PF07714 PF01437 PF01403 PF01833 7.8 IC50 ChEMBL;BindingDB
P35968 KDR Homo sapiens Human PF07679 PF00047 PF13895 PF22971 PF07714 PF21339 PF17988 PF22854 7.8 IC50 ChEMBL;BindingDB
P29317 EPHA2 Homo sapiens Human PF14575 PF25599 PF01404 PF00041 PF07714 PF00536 7.6 Kd ChEMBL;BindingDB
Q04912 MST1R Homo sapiens Human PF07714 PF01437 PF01403 PF01833 7.6 Kd ChEMBL
Q16832 DDR2 Homo sapiens Human PF21114 PF00754 PF07714 7.4 Kd ChEMBL
Q13882 PTK6 Homo sapiens Human PF07714 PF00017 PF00018 7.3 Kd ChEMBL
Q15375 EPHA7 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF00536 7.1 Kd ChEMBL
O43353 RIPK2 Homo sapiens Human PF00619 PF07714 7.0 Kd ChEMBL
P54760 EPHB4 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF00536 7.0 Kd ChEMBL
Q9Y572 RIPK3 Homo sapiens Human PF00069 PF12721 6.8 Kd ChEMBL
P07949 RET Homo sapiens Human PF00028 PF07714 PF17756 PF17812 PF17813 PF22540 6.8 Kd ChEMBL
Q9Y6E0 STK24 Homo sapiens Human PF20929 PF00069 6.7 Kd ChEMBL
P54756 EPHA5 Homo sapiens Human PF14575 PF25599 PF01404 PF00041 PF07714 PF00536 6.7 Kd ChEMBL
O15197 EPHB6 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF07647 6.6 Kd ChEMBL
Q15569 TESK1 Homo sapiens Human PF07714 6.5 Kd ChEMBL
P29323 EPHB2 Homo sapiens Human PF14575 PF25599 PF01404 PF07699 PF00041 PF07714 PF00536 6.5 Kd ChEMBL
P06239 LCK Homo sapiens Human PF07714 PF00017 PF00018 6.3 Kd ChEMBL
P04629 NTRK1 Homo sapiens Human PF13855 PF16920 PF07714 PF18613 6.2 Kd ChEMBL
P00519 ABL1 Homo sapiens Human PF08919 PF07714 PF00017 PF00018 6.2 Kd ChEMBL
Q9NYL2 MAP3K20 Homo sapiens Human PF07714 PF07647 6.2 Kd ChEMBL
P11274 BCR Homo sapiens Human PF09036 PF00168 PF19057 PF00620 PF00621 6.2 Kd ChEMBL
P42684 ABL2 Homo sapiens Human PF08919 PF07714 PF00017 PF00018 6.1 Kd ChEMBL
P09619 PDGFRB Homo sapiens Human PF00047 PF13927 PF25305 PF07714 6.0 Kd ChEMBL
Q76MJ5 ERN2 Homo sapiens Human PF00069 PF06479 6.0 Kd ChEMBL
Q14289 PTK2B Homo sapiens Human PF21477 PF00373 PF18038 PF03623 PF07714 6.0 Kd ChEMBL
DrugBank Target Actions (2)
Target Gene Target Name Action Type
P08581 MET Hepatocyte growth factor receptor modulator targets
P35968 KDR Vascular endothelial growth factor receptor 2 modulator targets